Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Determine the overall discriminatory ability of FET PET in the diagnosis of glioma grade II
(referring to the current diagnostic gold standard represented by the histopathology exam of
a tumor sample).